Colin Rutherford - May 4, 2022 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)

Role
Director
Signature
/s/ Justin J. File, attorney-in-fact
Stock symbol
EVFM
Transactions as of
May 4, 2022
Transactions value $
$0
Form type
4
Date filed
5/6/2022, 04:09 PM
Previous filing
May 13, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVFM Stock option (right to buy) Award $0 +6K $0.00 6K May 4, 2022 Common Stock 6K $2.47 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on May 5, 2022.
F2 The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 4, 2022. The option was awarded in connection with Mr. Rutherford's board and committee services.